1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Rotator Cuff Injury Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Rotator Cuff Injury Treatment Market, by Treatment
8.1.1. Surgical Treatment
8.1.1.1. Market Revenue and Forecast
8.1.2. Physiotherapy
8.1.2.1. Market Revenue and Forecast
8.1.3. Pharmaceutical Treatment
8.1.3.1. Market Revenue and Forecast
9.1. Rotator Cuff Injury Treatment Market, by Injury Severity
9.1.1. Full-Thickness
9.1.1.1. Market Revenue and Forecast
9.1.2. Partial-Thickness
9.1.2.1. Market Revenue and Forecast
10.1. Rotator Cuff Injury Treatment Market, by Cause
10.1.1. Acute
10.1.1.1. Market Revenue and Forecast
10.1.2. Degenerative
10.1.2.1. Market Revenue and Forecast
11.1. Rotator Cuff Injury Treatment Market, by End User
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Specialty clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Others
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Treatment
12.1.2. Market Revenue and Forecast, by Injury Severity
12.1.3. Market Revenue and Forecast, by Cause
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Treatment
12.1.5.2. Market Revenue and Forecast, by Injury Severity
12.1.5.3. Market Revenue and Forecast, by Cause
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Treatment
12.1.6.2. Market Revenue and Forecast, by Injury Severity
12.1.6.3. Market Revenue and Forecast, by Cause
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Treatment
12.2.2. Market Revenue and Forecast, by Injury Severity
12.2.3. Market Revenue and Forecast, by Cause
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Treatment
12.2.5.2. Market Revenue and Forecast, by Injury Severity
12.2.5.3. Market Revenue and Forecast, by Cause
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Treatment
12.2.6.2. Market Revenue and Forecast, by Injury Severity
12.2.6.3. Market Revenue and Forecast, by Cause
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Treatment
12.2.7.2. Market Revenue and Forecast, by Injury Severity
12.2.7.3. Market Revenue and Forecast, by Cause
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Treatment
12.2.8.2. Market Revenue and Forecast, by Injury Severity
12.2.8.3. Market Revenue and Forecast, by Cause
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Treatment
12.3.2. Market Revenue and Forecast, by Injury Severity
12.3.3. Market Revenue and Forecast, by Cause
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Treatment
12.3.5.2. Market Revenue and Forecast, by Injury Severity
12.3.5.3. Market Revenue and Forecast, by Cause
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Treatment
12.3.6.2. Market Revenue and Forecast, by Injury Severity
12.3.6.3. Market Revenue and Forecast, by Cause
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Treatment
12.3.7.2. Market Revenue and Forecast, by Injury Severity
12.3.7.3. Market Revenue and Forecast, by Cause
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Treatment
12.3.8.2. Market Revenue and Forecast, by Injury Severity
12.3.8.3. Market Revenue and Forecast, by Cause
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Treatment
12.4.2. Market Revenue and Forecast, by Injury Severity
12.4.3. Market Revenue and Forecast, by Cause
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Treatment
12.4.5.2. Market Revenue and Forecast, by Injury Severity
12.4.5.3. Market Revenue and Forecast, by Cause
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Treatment
12.4.6.2. Market Revenue and Forecast, by Injury Severity
12.4.6.3. Market Revenue and Forecast, by Cause
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Treatment
12.4.7.2. Market Revenue and Forecast, by Injury Severity
12.4.7.3. Market Revenue and Forecast, by Cause
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Treatment
12.4.8.2. Market Revenue and Forecast, by Injury Severity
12.4.8.3. Market Revenue and Forecast, by Cause
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Treatment
12.5.2. Market Revenue and Forecast, by Injury Severity
12.5.3. Market Revenue and Forecast, by Cause
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Treatment
12.5.5.2. Market Revenue and Forecast, by Injury Severity
12.5.5.3. Market Revenue and Forecast, by Cause
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Treatment
12.5.6.2. Market Revenue and Forecast, by Injury Severity
12.5.6.3. Market Revenue and Forecast, by Cause
12.5.6.4. Market Revenue and Forecast, by End User
13.1. Arthrex, Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Zimmer Biomet
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. FH ORTHOPEDICS S.A.S
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Integra LifeSciences
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Reckitt Benckiser Group PLC
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Evolutis India Pvt. Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Johnson & Johnson
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. GlaxoSmithKline PLC
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. CONMED Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Arthrex, Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
